ARTICLE | Company News
Copernicus, Cystic Fibrosis Foundation pulmonary, gene/cell therapy news
February 19, 2007 8:00 AM UTC
Copernicus will receive up to $5.2 million from Cystic Fibrosis Foundation Therapeutics Inc., the drug discovery arm of the foundation, to develop CFx non-viral gene therapy to treat cystic fibrosis ...